Masjedi et al. have shown that in various tumors, including breast, liver, and gastric cancers, OSM can activate the JAK/STAT signaling pathway—particularly STAT3—thereby enhancing cancer cell invasiveness, metastasis, and resistance to treatment, which promotes tumor invasion and metastasis [40]. The gene discussed is STAT3; the disease is neoplasm.